1 |
吴国明,钱桂生. 非小细胞肺癌靶向治疗研究进展及新理念[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(4): 405-408.
|
2 |
赫 捷,李 霓,陈万青,等. 中国肺癌筛查与早诊早治指南(2021,北京)[J]. 中国肿瘤,2021, 30(2): 81-111.
|
3 |
中华医学会呼吸病学分会. 早期肺癌诊断中国专家共识(2023年版)[J]. 中华结核和呼吸杂志,2023, 46(1): 1-18.
|
4 |
Mazzone PJ, Lam L. Evaluating the patient with a pulmonary nodule:A review[J]. JAMA, 2022, 327(3): 264-273.
|
5 |
邹明珠,蓝博文,林观兰,等. 螺旋CT形态学特征在肺结节良恶性诊断中的临床意义[J/CD]. 中华肺部疾病杂志(电子版), 2023, 16(5): 729-730.
|
6 |
李 强. 螺旋CT动态增强扫描在孤立性肺结节良恶性鉴别诊断中的应用探讨[J]. 中国现代药物应用,2024, 18(11): 75-78.
|
7 |
Pan H, Renaud L, Chaligne R, et al. Discovery of candidate DNA methylation cancer driver genes[J]. Cancer Discov, 2021,11(9): 2266-2281.
|
8 |
Li P, Liu S, Du L, et al. Liquid biopsies based on DNA methylation as biomarkers for the detection and prognosis of lung cancer[J]. Clin Epigenetics, 2022,14(1): 118.
|
9 |
Bin Y, Ding Y, Xiao W, et al. RASSF1A: A promising target for the diagnosis and treatment of cancer[J]. Clin Chim Acta, 2020, 504: 98-108.
|
10 |
Li N, Zeng Y, Huang J. Signaling pathways and clinical application of RASSF1A and SHOX2 in lung cancer[J]. J Cancer Res Clin Oncol, 2020, 146(6): 1379-1393.
|
11 |
Ren M, Wang C, Sheng D, et al. Methylation analysis of SHOX2 and RASSF1A in bronchoalveolar lavage fluid for early lung cancer diagnosis[J]. Ann Diagn Pathol, 2017, 27: 57-61.
|
12 |
Hutchinson BD, Shroff GS, Truong MT, et al. Spectrum of Lung Adenocarcinoma[J]. Semin Ultrasound CT MR, 2019, 40(3): 255-264.
|
13 |
Kalchiem-Dekel O, Connolly JG, Lin IH, et al. Shape-sensing robotic-assisted bronchoscopy in the diagnosis of pulmonary parenchymal lesions[J]. Chest, 2022, 161(2): 572-582.
|
14 |
Nadig TR, Thomas N, Nietert PJ, et al. Guided bronchoscopy for the evaluation of pulmonary lesions: An updated Meta-analysis[J]. Chest, 2023, 163(6): 1589-1598.
|
15 |
Zhong Q, Wang Y, Liang C, et al. Combined methylation of SHOX2 and RASSF1A genes in fiagnosing malignant pleural effusion[J]. Discov Med, 2023, 35(178): 845-852.
|
16 |
Lu H, Lin D. Diagnostic value of exfoliated tumor cells combined with DNA methylation in bronchoalveolar lavage fluid for lung cancer[J]. Medicine (Baltimore), 2023, 102(36): 1-6.
|
17 |
Shi J, Chen X, Zhang L, et al. Performance evaluation of SHOX2 and RASSF1A methylation for the aid in diagnosis of lung cancer based on the analysis of FFPE specimen[J]. Front Oncol, 2020, 10: 1-6.
|
18 |
Domagala-Kulawik J. The relevance of bronchoalveolar lavage fluid analysis for lung cancer patients[J]. Expert Rev Respir Med, 2020, 14(3): 329-337.
|
19 |
朱东平,李海峰,冯俊飞,等. 肺部结节或肿块患者肺泡灌洗液SHOX2和RASSF1A基因甲基化在肺癌诊断中的价值[J]. 昆明医科大学学报,2024, 45(3): 106-111.
|
20 |
陈瑞英,刘 雅,孙 婷,等. 支气管肺泡灌洗液中SHOX2和RASSF1A基因甲基化检测对肺癌的诊断价值[J]. 郑州大学学报(医学版), 2019, 54(5): 732-736.
|
21 |
Ma S, Yu X, Jin X, et al. The usefulness of liquid-based cytology of bronchoalveolar lavage fluid combined with bronchial brush specimens in lung cancer diagnosis[J]. J Int Med Res, 2022, 50(11): 1-6.
|
22 |
王 斌,王 静,黄赞胜,等. 肺超声可视化支气管肺泡灌洗在肺外周病灶诊断中的应用[J/CD]. 中华肺部疾病杂志(电子版), 2023, 16(4): 466-470.
|
23 |
Zheng X, Wang L, Chen J, et al. Diagnostic value of radial endobronchial ultrasonographic features in predominant solid peripheral pulmonary lesions[J]. J Thorac Dis, 2020, 12(12): 7656-7665.
|
24 |
Choi J, Zo S, Kim JH, et al. Nondiagnostic, radial-probe endobronchial ultrasound-guided biopsy for peripheral lung lesions: The added value of radiomics from ultrasound imaging for predicting malignancy[J]. Thorac Cancer, 2023, 14(2): 177-185.
|
25 |
何正强,傅应云,李亚珍,等. 支气管腔内超声特征对肺部结节良恶性的预测价值[J]. 国际呼吸杂志,2018(22): 1703-1707.
|
26 |
Kurimoto N, Murayama M, Yoshioka S, et al. Analysis of the internal structure of peripheral pulmonary lesions using endobronchial ultrasonography[J]. Chest, 2002, 122(6): 1887-1894.
|
27 |
王 慧,魏美慧,张晓菊. 提高以磨玻璃结节为表现的早期肺癌诊治水平[J]. 结核与肺部疾病杂志,2021, 2(3): 193-196.
|
28 |
Li T, Liu Y, Zhang W, et al. A rapid liquid biopsy of lung cancer by separation and detection of exfoliated tumor cells from bronchoalveolar lavage fluid with a dual-layer "PERFECT" filter system[J]. Theranostics, 2020, 10(14): 6517-6529.
|
29 |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68: 394-424.
|
30 |
Silvestri GA, Gonzalez AV, Jantz MA, et al. Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines[J]. Chest, 2013, 143: e211S-e50S.
|